Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=arryLatest Financial News for Array BioPharma Inc.en-usTue, 22 Dec 2009 22:05:12 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=128n49396/*http%3A//denver.bizjournals.com/denver/stories/2009/12/21/daily24.html?ana=yfcpcyahoo_finance/3919343375Tue, 22 Dec 2009 22:05:12 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=1283uu2qn/*http%3A//denver.bizjournals.com/denver/stories/2009/12/21/daily12.html?ana=yfcpcyahoo_finance/3064953585Mon, 21 Dec 2009 22:05:14 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://us.rd.yahoo.com/finance/editorial/xbizwk/SIG=12egls3v5/*http%3A//www.businessweek.com/investor/content/dec2009/pi20091215_701304.htm?campaign_id=yhooyahoo_finance/477749943Wed, 16 Dec 2009 13:09:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091216/180414.html?.v=1DALLAS -- InvestorSoup.com announces an investment report featuring Array BioPharma Inc. . The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.yahoo_finance/1944680507Wed, 16 Dec 2009 11:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=128ev2np2/*http%3A//denver.bizjournals.com/denver/stories/2009/12/14/daily38.html?ana=yfcpcyahoo_finance/529334438Tue, 15 Dec 2009 23:05:23 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091215/us_wall_street_stocks.html?.v=2The following stocks were among those that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:yahoo_finance/2452882501Tue, 15 Dec 2009 22:27:35 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13822rosp/*http%3A//seekingalpha.com/article/178328-equities-update-stocks-finish-lower-as-inflation-signs-emerge?source=yahooyahoo_finance/3810197956Tue, 15 Dec 2009 21:30:34 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091215/us_array_biopharma_mover.html?.v=1Shares of Array BioPharma Inc. surged Tuesday after the company struck a development deal with Amgen Inc. worth $60 million upfront for a potential type 2 diabetes treatment.yahoo_finance/1382617575Tue, 15 Dec 2009 18:56:24 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=130f9qe93/*http%3A//www.fool.com/investing/high-growth/2009/12/15/its-nice-to-have-friends-with-cash.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/472083716Tue, 15 Dec 2009 18:10:28 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091215/180342.html?.v=1CALGARY, Alberta -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Array BioPharma Inc., . Emerging Stock Report is currently offering a complimentary trial subscription to the investment community.yahoo_finance/1473659120Tue, 15 Dec 2009 16:04:44 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091215/2640_id.html?.v=1Shares of Array BioPharma surged on Tuesday after the small-cap company signed a $60 million deal.yahoo_finance/2037873791Tue, 15 Dec 2009 15:03:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091215/us_amgen_array_biopharma_agreement.html?.v=1Biotech drug developer Amgen Inc. has entered an agreement with Array BioPharma Inc. to develop a potential treatment for type 2 diabetes, the companies said late Monday.yahoo_finance/3676453153Tue, 15 Dec 2009 13:51:47 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=135grtqks/*http%3A//www.thestreet.com/_yahoo/story/10645867/1/ja-solar-array-biopharma-early-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1109291740Tue, 15 Dec 2009 13:20:41 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=128fe2svr/*http%3A//denver.bizjournals.com/denver/stories/2009/12/14/daily22.html?ana=yfcpcyahoo_finance/2681466516Tue, 15 Dec 2009 05:05:13 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091214/20091214006336.html?.v=1BOULDER, Colo. & THOUSAND OAKS, Calif.----Array BioPharma Inc. and Amgen Inc. today announced that they entered into an agreement granting Amgen exclusive worldwide rights to Array’s small-molecule glucokinase activator program, including ARRY-403, currently being tested in a Phase 1 clinical trial in patients with Type 2 diabetes.yahoo_finance/2585462789Mon, 14 Dec 2009 23:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/twst/091214/suisse16.html?.v=1yahoo_finance/2283720492Mon, 14 Dec 2009 16:19:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091214/28267.html?.v=2yahoo_finance/473648507Mon, 14 Dec 2009 14:54:47 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091214/arry8-k.htmlyahoo_finance/3570654707Mon, 14 Dec 2009 11:03:30 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091212/20091212005010.html?.v=1BOULDER, Colo.----Array BioPharma Inc. today announced positive interim results of its novel, small molecule HER2 inhibitor, ARRY-380, in a Phase 1 trial in advanced cancer patients.yahoo_finance/1369327671Sat, 12 Dec 2009 23:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/twst/091210/shove12.html?.v=1yahoo_finance/1291452273Thu, 10 Dec 2009 17:00:00 Etc/GMT